Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Mission Bio Raises $30M in Series B Financing

Mission Bio Raises $30M in Series B Financing

Dec 13, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Mission Bio said today that it has raised $30 million in a Series B financing round led by Agilent Technologies, Cota Capital, LAM Capital, and Mayfield, bringing its total financing to more than $50 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

US Concerns Over BGI Testing in Middle East

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

Confidence Boost

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.

What's Popular?

In Business News

  1. Roche Acquires Sequencing Company Stratos Genomics

  2. BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

  3. Agilent Posts Flat Q2 2020 Revenue Growth

  4. Volpara Solutions, Ambry Genetics Form Breast Cancer Management Alliance

  5. 10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.